Mining for Microarray Gold

The use of high-throughput gene expression analysis technologies, such as microarrays, yields reams of data. Unfortunately, data stemming from competing and alternate technologies is often stored in a variety of formats, making comprehensive analyses difficult. Kirkland, Wash.-based Rosetta Inpharmatics Inc. offers a product that now enables scientists to join all of their gene expression data in a single location, and to mine that data for nuggets of gold unimaginable when the experiments were

Written byJeffrey Perkel
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The Rosetta Resolver System, version 2.0, "provides storage, retrieval, and analysis mechanisms for large volumes of gene expression data from a wide variety of technologies," according to Douglas Bassett, senior director of biosoftware products at Rosetta. Thus, it can be used to integrate data from nylon arrays, microarrays, and SAGE experiments, for example. It also provides "powerful statistical algorithms and error models for each technology ... which allow us to predict, based on the past behavior of a certain gene expression platform technology, ... the quality statistics associated with each measurement," says Bassett. This means that the system can determine how much weight to assign each data point in subsequent analyses. The advantage of this approach is that every experiment added to the database increases the value of the entire database. Thus, whereas it was once common to analyze only a subset of the limited number of datasets stored in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas